Provider [Proveedor]
QP90-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2024
Fecha de entrada en vigencia del programa: 08 de noviembre de 2023